Use of lytic toxins and toxin conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11819649

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Agents are provided which are capable of inhibiting the cell division cycle in a target cell of interest. The agents comprise first and second components, wherein the first component is a targeting moiety which is capable of directing the second component to the target cell of interest. The second component is capable of inhibiting the cell division cycle in the target cell of interest. The agents are preferably provided in the form of conjugates, and the second component is preferably a cytolethal distending toxin. Methods for the preparation of the agents, and the use thereof for treating proliferative cell disorders and intracellular pathogens are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTAXIN LIMITEDUNITS 4-10 THE QUADRANT BARTON LANE ABINGDON OXFORDSHIRE OX14 3YS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Charlton, Susan Castle Cary, GB 2 1
Henderson, Ian Frederick, MD 48 395
Purdy, Desmond Salisbury, GB 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation